Literature for mepazine (C14.026 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2018
1. Kip,E., Staal,J., Tima,H.G., Verstrepen,L., Romano,M., Lemeire,K., Suin,V., Hamouda,A., Baens,M., Libert,C., Kalai,M., Van Gucht,S. and Beyaert,R.
   Inhibition of MALT1 decreases neuroinflammation and pathogenicity of virulent rabies virus in mice
   J Virol92, e00720-18-e00720-18. PubMed  Europe PubMed DOI  I
2. Li,Y., Huang,S., Huang,X., Li,X., Falcon,A., Soutar,A., Bornancin,F., Jiang,Z., Xin,H.B. and Fu,M.
   Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression
   Cell Signal50, 1-8. PubMed  Europe PubMed DOI  I
2016
3. Liu,W., Guo,W., Hang,N., Yang,Y., Wu,X., Shen,Y., Cao,J., Sun,Y. and Xu,Q.
   MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-kappaB and NLRP3 inflammasome activation
   Oncotarget7, 30536-30549. PubMed  Europe PubMed DOI  I
2015
4. Nagel,D., Bognar,M., Eitelhuber,A.C., Kutzner,K., Vincendeau,M. and Krappmann,D.
   Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma
   Oncotarget6, 42232-42242. PubMed  Europe PubMed DOI  I
2014
5. Mc Guire,C., Elton,L., Wieghofer,P., Staal,J., Voet,S., Demeyer,A., Nagel,D., Krappmann,D., Prinz,M., Beyaert,R. and Van Loo,G.
   Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis
   J Neuroinflammation11, 124-124. PubMed  Europe PubMed DOI  I
2013
6. Burgess,D.J.
   Anticancer drugs: assault on MALT1
   Nat Rev Drug Discov12, 100-100. PubMed  Europe PubMed DOI  I
7. Burgess,D.J.
   Therapeutics: assault on MALT1
   Nat Rev Cancer13, 80-80. PubMed  Europe PubMed DOI  I
2012
8. Nagel,D., Spranger,S., Vincendeau,M., Grau,M., Raffegerst,S., Kloo,B., Hlahla,D., Neuenschwander,M., Peter von Kries,J., Hadian,K., Dorken,B., Lenz,P., Lenz,G., Schendel,D.J. and Krappmann,D.
   Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL
   Cancer Cell22, 825-837. PubMed  Europe PubMed DOI  I